Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned from ERICCA and RIPHeart

Circulation Research

Volumn 118, Issue 7, 2016, Pages 1052-1054

  Garratt, Kirk N ^a   Whittaker, Peter ^b   Przyklenk, Karin ^b  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR DISEASE; CLINICAL OUTCOME; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; HEART SURGERY; HUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REMOTE ISCHEMIC CONDITIONING; REVIEW;

EID: 84983294812     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.308102     Document Type: Review

References (20)

1. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P, Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993 87 893 899
2. Przyklenk K, Whittaker P, Genesis of remote conditioning: action at a distance-'hypotheses non fingo'? J Cardiovasc Med (Hagerstown) 2013 14 180 186. doi: 10.2459/JCM.0b013e328358c8eb
3. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R, Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002 106 2881 2883
4. Sharma V, Marsh R, Cunniffe B, Cardinale M, Yellon DM, Davidson SM, From protecting the heart to improving athletic performance-the benefits of local and remote ischaemic preconditioning. Cardiovasc Drugs Ther 2015;29:573-588.
5. Heusch G, Bøtker HE, Przyklenk K, Redington A, Yellon D, Remote ischemic conditioning. J Am Coll Cardiol 2015 65 177 195. doi: 10.1016/j.jacc.2014.10.031
6. Ovize M, Thibault H, Przyklenk K, Myocardial conditioning: opportunities for clinical translation. Circ Res 2013 113 439 450. doi: 10.1161/CIRCRESAHA.113.300764
7. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME, Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011 305 585 591. doi: 10.1001/jama.2011.99
8. Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, ERICCA Trial Investigators Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015 373 1408 1417. doi: 10.1056/NEJMoa1413534
9. Meybohm P, Bein B, Brosteanu O, RIPHeart Study Collaborators A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015 373 1397 1407. doi: 10.1056/NEJMoa1413579
10. Zaugg M, Lucchinetti E, Remote ischemic preconditioning in cardiac surgery-ineffective and risky? N Engl J Med 2015 373 1470 1472. doi: 10.1056/NEJMe1510338
11. Heusch G, Gersh BJ, ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! Eur Heart J 2016 37 200 202. doi: 10.1093/eurheartj/ehv606
12. Iliodromitis EK, Andreadou I, Iliodromitis K, Dagres N, Ischemic and postischemic conditioning of the myocardium in clinical practice: challenges, expectations and obstacles. Cardiology 2014 129 117 125. doi: 10.1159/000362499
13. Johnsen J, Pryds K, Salman R, Løfgren B, Kristiansen SB, Bøtker HE, The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection. Basic Res Cardiol 2016 111 10. doi: 10.1007/s00395-016-0529-6
14. Przyklenk K, Ischaemic conditioning: pitfalls on the path to clinical translation. Br J Pharmacol 2015 172 1961 1973. doi: 10.1111/bph.13064
15. Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, Sørensen HT, Bøtker HE, CONDI Investigators Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 2014 35 168 175. doi: 10.1093/eurheartj/eht369
16. Kleinbongard P, Neuhäuser M, Thielmann M, Kottenberg E, Peters J, Jakob H, Heusch G, Confounders of Cardioprotection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting. Cardiology 2016 133 128 133. doi: 10.1159/000441216
17. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J, Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol-a clinical trial. Acta Anaesthesiol Scand 2012 56 30 38. doi: 10.1111/j.1399-6576.2011.02585.x
18. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M, STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 2012 110 111 115. doi: 10.1161/CIRCRESAHA.111.259556
19. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G, Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014 147 376 382. doi: 10.1016/j.jtcvs.2013.01.005
20. Shravah J, Wang B, Pavlovic M, Kumar U, Chen DD, Luo H, Ansley DM, Propofol mediates signal transducer and activator of transcription 3 activation and crosstalk with phosphoinositide 3-kinase/AKT. JAKSTAT 2014 3 e29554. doi: 10.4161/jkst.29554